Pan-Antagonists for the Androgen Receptor and Androgen Receptor Mutants Associated with Anti-Androgen Withdrawal

Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.

Patents:
US 20,090,270,512

Inventor(s): KOH JOHN TZE-TZUN [US]; MCGINLEY PAULA LYNN [US]; PAN HONGMU [US]

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent